Viewing Study NCT06737250


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2025-12-27 @ 12:43 AM
Study NCT ID: NCT06737250
Status: RECRUITING
Last Update Posted: 2024-12-17
First Post: 2024-12-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL
Sponsor: NOBO Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module